Sex
|
Age at tumour sampling
|
Stage at tumour sampling*
|
Histology
|
Prior chemotherapy
|
---|
Male
|
39
|
Metastatic
|
Signet-ring cell
|
Yes
|
Female
|
58
|
Metastatic
|
Signet-ring cell
|
Yes
|
Male
|
60
|
Metastatic
|
Intestinal
|
Yes
|
Male
|
58
|
Localized
|
Diffuse
|
Yes
|
Female
|
71
|
Localized
|
Diffuse
|
Yes
|
Female
|
54
|
Metastatic
|
Signet-ring cell
|
Yes
|
Male
|
66
|
Localized
|
Intestinal
|
No
|
Male
|
75
|
Localized
|
Intestinal
|
Yes
|
Female
|
67
|
Metastatic
|
Diffuse
|
Yes
|
Male
|
74
|
Localized
|
Intestinal
|
Yes
|
Female
|
70
|
Localized
|
Intestinal
|
No
|
Male
|
70
|
Localized
|
Intestinal
|
Yes
|
Male
|
70
|
Localized
|
Intestinal
|
Yes
|
Female
|
61
|
Localized
|
Intestinal
|
No
|
Female
|
88
|
Localized
|
Intestinal
|
No
|
Male
|
74
|
Localized
|
Intestinal
|
Yes
|
- *Patients with localized disease underwent curative surgery and tumour sampling was from the primary tumour. Patients with metastatic disease had carcinosis, were planned for cytoreductive surgery and intraperitoneal chemotherapy and tumour sampling was from carcinosis.